Skip to main content
Top
Published in:

Open Access 01-12-2023 | Schizophrenia | Research

Exploration of the role of emotional expression of treatment-resistant schizophrenia patients having followed virtual reality therapy: a content analysis

Authors: Alexandre Hudon, Veronica Lammatteo, Sophie Rodrigues-Coutlée, Laura Dellazizzo, Sabrina Giguère, Kingsada Phraxayavong, Stéphane Potvin, Alexandre Dumais

Published in: BMC Psychiatry | Issue 1/2023

Login to get access

Abstract

Background

Emotional responses are an important component of psychotherapeutic processes. Avatar therapy (AT) is a virtual reality-based therapy currently being developed and studied for patients suffering from treatment resistant schizophrenia. Considering the importance of identifying emotions in therapeutical processes and their impact on the therapeutic outcome, an exploration of such emotions is needed.

Methods

The aim of this study is to identify the underlying emotions at the core of the patient-Avatar interaction during AT by content analysis of immersive sessions transcripts and audio recordings. A content analysis of AT transcripts and audio recordings using iterative categorization was conducted for 16 patients suffering from TRS who underwent AT between 2017 and 2022 (128 transcripts and 128 audio recordings). An iterative categorization technique was conducted to identify the different emotions expressed by the patient and the Avatar during the immersive sessions.

Results

The following emotions were identified in this study: Anger, Contempt/ Disgust, Fear, Sadness, Shame/ Embarrassment, Interest, Surprise, Joy and Neutral. Patients expressed mostly neutral, joy and anger emotions whereas the Avatar expressed predominantly interest, disgust/contempt, and neutral emotions.

Conclusions

This study portrays a first qualitative insight on the emotions that are expressed in AT and serves as a steppingstone for further investigation in the role of emotions in the therapeutic outcomes of AT.
Literature
1.
go back to reference Kahn RS, Sommer IE, Murray RM, Meyer-Lindenberg A, Weinberger DR, Cannon TD, et al. Schizophrenia Nat Rev Dis Primers. 2015;1:15067.PubMedCrossRef Kahn RS, Sommer IE, Murray RM, Meyer-Lindenberg A, Weinberger DR, Cannon TD, et al. Schizophrenia Nat Rev Dis Primers. 2015;1:15067.PubMedCrossRef
2.
go back to reference Jin H, Mosweu I. The Societal cost of Schizophrenia: a systematic review. PharmacoEconomics. 2017;35(1):25–42.PubMedCrossRef Jin H, Mosweu I. The Societal cost of Schizophrenia: a systematic review. PharmacoEconomics. 2017;35(1):25–42.PubMedCrossRef
3.
go back to reference Kadakia A, Catillon M, Fan Q, Williams GR, Marden JR, Anderson A et al. The Economic Burden of Schizophrenia in the United States. J Clin Psychiatry. 2022;83(6). Kadakia A, Catillon M, Fan Q, Williams GR, Marden JR, Anderson A et al. The Economic Burden of Schizophrenia in the United States. J Clin Psychiatry. 2022;83(6).
5.
go back to reference McCutcheon RA, Reis Marques T, Howes OD. Schizophrenia-An Overview. JAMA Psychiatry. 2020;77(2):201–10.PubMedCrossRef McCutcheon RA, Reis Marques T, Howes OD. Schizophrenia-An Overview. JAMA Psychiatry. 2020;77(2):201–10.PubMedCrossRef
6.
go back to reference Abplanalp SJ, Braff DL, Light GA, Nuechterlein KH, Green MF, Consortium on the Genetics of S. Understanding connections and boundaries between positive symptoms, negative symptoms, and role functioning among individuals with Schizophrenia: A Network Psychometric Approach. JAMA Psychiatry. 2022;79(10):1014–22.PubMedCrossRef Abplanalp SJ, Braff DL, Light GA, Nuechterlein KH, Green MF, Consortium on the Genetics of S. Understanding connections and boundaries between positive symptoms, negative symptoms, and role functioning among individuals with Schizophrenia: A Network Psychometric Approach. JAMA Psychiatry. 2022;79(10):1014–22.PubMedCrossRef
7.
go back to reference Brisch R, Saniotis A, Wolf R, Bielau H, Bernstein HG, Steiner J, et al. The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue. Front Psychiatry. 2014;5:47.PubMedPubMedCentral Brisch R, Saniotis A, Wolf R, Bielau H, Bernstein HG, Steiner J, et al. The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue. Front Psychiatry. 2014;5:47.PubMedPubMedCentral
8.
go back to reference McCollum LA, Roberts RC. Uncovering the role of the nucleus accumbens in schizophrenia: a postmortem analysis of tyrosine hydroxylase and vesicular glutamate transporters. Schizophr Res. 2015;169(1–3):369–73.PubMedPubMedCentralCrossRef McCollum LA, Roberts RC. Uncovering the role of the nucleus accumbens in schizophrenia: a postmortem analysis of tyrosine hydroxylase and vesicular glutamate transporters. Schizophr Res. 2015;169(1–3):369–73.PubMedPubMedCentralCrossRef
9.
go back to reference Danielsson K, Stomberg R, Adermark L, Ericson M, Soderpalm B. Differential dopamine release by psychosis-generating and non-psychosis-generating addictive substances in the nucleus accumbens and dorsomedial striatum. Transl Psychiatry. 2021;11(1):472.PubMedPubMedCentralCrossRef Danielsson K, Stomberg R, Adermark L, Ericson M, Soderpalm B. Differential dopamine release by psychosis-generating and non-psychosis-generating addictive substances in the nucleus accumbens and dorsomedial striatum. Transl Psychiatry. 2021;11(1):472.PubMedPubMedCentralCrossRef
10.
11.
go back to reference Correll CU, Schooler NR. Negative symptoms in Schizophrenia: a review and clinical guide for Recognition, Assessment, and treatment. Neuropsychiatr Dis Treat. 2020;16:519–34.PubMedPubMedCentralCrossRef Correll CU, Schooler NR. Negative symptoms in Schizophrenia: a review and clinical guide for Recognition, Assessment, and treatment. Neuropsychiatr Dis Treat. 2020;16:519–34.PubMedPubMedCentralCrossRef
12.
go back to reference Butler T, Weisholtz D, Isenberg N, Harding E, Epstein J, Stern E, et al. Neuroimaging of frontal-limbic dysfunction in schizophrenia and epilepsy-related psychosis: toward a convergent neurobiology. Epilepsy Behav. 2012;23(2):113–22.PubMedCrossRef Butler T, Weisholtz D, Isenberg N, Harding E, Epstein J, Stern E, et al. Neuroimaging of frontal-limbic dysfunction in schizophrenia and epilepsy-related psychosis: toward a convergent neurobiology. Epilepsy Behav. 2012;23(2):113–22.PubMedCrossRef
14.
go back to reference Smith RC, Leucht S, Davis JM. Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis. Psychopharmacology. 2019;236(2):545–59.PubMedCrossRef Smith RC, Leucht S, Davis JM. Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis. Psychopharmacology. 2019;236(2):545–59.PubMedCrossRef
15.
go back to reference Zhu Y, Krause M, Huhn M, Rothe P, Schneider-Thoma J, Chaimani A, et al. Antipsychotic drugs for the acute treatment of patients with a first episode of schizophrenia: a systematic review with pairwise and network meta-analyses. Lancet Psychiatry. 2017;4(9):694–705.PubMedCrossRef Zhu Y, Krause M, Huhn M, Rothe P, Schneider-Thoma J, Chaimani A, et al. Antipsychotic drugs for the acute treatment of patients with a first episode of schizophrenia: a systematic review with pairwise and network meta-analyses. Lancet Psychiatry. 2017;4(9):694–705.PubMedCrossRef
16.
go back to reference Lally J, MacCabe JH. Antipsychotic medication in schizophrenia: a review. Br Med Bull. 2015;114(1):169–79.PubMedCrossRef Lally J, MacCabe JH. Antipsychotic medication in schizophrenia: a review. Br Med Bull. 2015;114(1):169–79.PubMedCrossRef
18.
go back to reference Nucifora FC Jr, Woznica E, Lee BJ, Cascella N, Sawa A. Treatment resistant schizophrenia: clinical, biological, and therapeutic perspectives. Neurobiol Dis. 2019;131:104257.PubMedCrossRef Nucifora FC Jr, Woznica E, Lee BJ, Cascella N, Sawa A. Treatment resistant schizophrenia: clinical, biological, and therapeutic perspectives. Neurobiol Dis. 2019;131:104257.PubMedCrossRef
19.
go back to reference Bioque M, Parellada E, Garcia-Rizo C, Amoretti S, Fortea A, Oriolo G, et al. Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: a retrospective 6-month mirror-image study. Eur Psychiatry. 2020;63(1):e71.PubMedPubMedCentralCrossRef Bioque M, Parellada E, Garcia-Rizo C, Amoretti S, Fortea A, Oriolo G, et al. Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: a retrospective 6-month mirror-image study. Eur Psychiatry. 2020;63(1):e71.PubMedPubMedCentralCrossRef
20.
go back to reference Correll CU, Rubio JM, Inczedy-Farkas G, Birnbaum ML, Kane JM, Leucht S. Efficacy of 42 pharmacologic cotreatment strategies added to antipsychotic monotherapy in Schizophrenia: systematic overview and Quality Appraisal of the Meta-analytic evidence. JAMA Psychiatry. 2017;74(7):675–84.PubMedPubMedCentralCrossRef Correll CU, Rubio JM, Inczedy-Farkas G, Birnbaum ML, Kane JM, Leucht S. Efficacy of 42 pharmacologic cotreatment strategies added to antipsychotic monotherapy in Schizophrenia: systematic overview and Quality Appraisal of the Meta-analytic evidence. JAMA Psychiatry. 2017;74(7):675–84.PubMedPubMedCentralCrossRef
21.
go back to reference Potkin SG, Kane JM, Correll CU, Lindenmayer JP, Agid O, Marder SR, et al. The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research. NPJ Schizophr. 2020;6(1):1.PubMedPubMedCentralCrossRef Potkin SG, Kane JM, Correll CU, Lindenmayer JP, Agid O, Marder SR, et al. The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research. NPJ Schizophr. 2020;6(1):1.PubMedPubMedCentralCrossRef
22.
go back to reference Bighelli I, Salanti G, Huhn M, Schneider-Thoma J, Krause M, Reitmeir C, et al. Psychological interventions to reduce positive symptoms in schizophrenia: systematic review and network meta-analysis. World Psychiatry. 2018;17(3):316–29.PubMedPubMedCentralCrossRef Bighelli I, Salanti G, Huhn M, Schneider-Thoma J, Krause M, Reitmeir C, et al. Psychological interventions to reduce positive symptoms in schizophrenia: systematic review and network meta-analysis. World Psychiatry. 2018;17(3):316–29.PubMedPubMedCentralCrossRef
23.
go back to reference Bighelli I, Huhn M, Schneider-Thoma J, Krause M, Reitmeir C, Wallis S, et al. Response rates in patients with schizophrenia and positive symptoms receiving cognitive behavioural therapy: a systematic review and single-group meta-analysis. BMC Psychiatry. 2018;18(1):380.PubMedPubMedCentralCrossRef Bighelli I, Huhn M, Schneider-Thoma J, Krause M, Reitmeir C, Wallis S, et al. Response rates in patients with schizophrenia and positive symptoms receiving cognitive behavioural therapy: a systematic review and single-group meta-analysis. BMC Psychiatry. 2018;18(1):380.PubMedPubMedCentralCrossRef
24.
go back to reference Jauhar S, McKenna PJ, Radua J, Fung E, Salvador R, Laws KR. Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias. Br J Psychiatry. 2014;204(1):20–9.PubMedCrossRef Jauhar S, McKenna PJ, Radua J, Fung E, Salvador R, Laws KR. Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias. Br J Psychiatry. 2014;204(1):20–9.PubMedCrossRef
25.
go back to reference Leff J, Williams G, Huckvale M, Arbuthnot M, Leff AP. Avatar therapy for persecutory auditory hallucinations: what is it and how does it work? Psychosis. 2014;6(2):166–76.PubMedCrossRef Leff J, Williams G, Huckvale M, Arbuthnot M, Leff AP. Avatar therapy for persecutory auditory hallucinations: what is it and how does it work? Psychosis. 2014;6(2):166–76.PubMedCrossRef
26.
go back to reference Craig TK, Rus-Calafell M, Ward T, Leff JP, Huckvale M, Howarth E, et al. AVATAR therapy for auditory verbal hallucinations in people with psychosis: a single-blind, randomised controlled trial. Lancet Psychiatry. 2018;5(1):31–40.PubMedPubMedCentralCrossRef Craig TK, Rus-Calafell M, Ward T, Leff JP, Huckvale M, Howarth E, et al. AVATAR therapy for auditory verbal hallucinations in people with psychosis: a single-blind, randomised controlled trial. Lancet Psychiatry. 2018;5(1):31–40.PubMedPubMedCentralCrossRef
27.
go back to reference Aali G, Kariotis T, Shokraneh F. Avatar Therapy for people with schizophrenia or related disorders. Cochrane Database Syst Rev. 2020;5(5):CD011898.PubMed Aali G, Kariotis T, Shokraneh F. Avatar Therapy for people with schizophrenia or related disorders. Cochrane Database Syst Rev. 2020;5(5):CD011898.PubMed
28.
go back to reference du Sert OP, Potvin S, Lipp O, Dellazizzo L, Laurelli M, Breton R, et al. Virtual reality therapy for refractory auditory verbal hallucinations in schizophrenia: a pilot clinical trial. Schizophr Res. 2018;197:176–81.PubMedCrossRef du Sert OP, Potvin S, Lipp O, Dellazizzo L, Laurelli M, Breton R, et al. Virtual reality therapy for refractory auditory verbal hallucinations in schizophrenia: a pilot clinical trial. Schizophr Res. 2018;197:176–81.PubMedCrossRef
29.
go back to reference Beaudoin M, Potvin S, Machalani A, Dellazizzo L, Bourguignon L, Phraxayavong K, et al. The therapeutic processes of avatar therapy: a content analysis of the dialogue between treatment-resistant patients with schizophrenia and their avatar. Clin Psychol Psychother. 2021;28(3):500–18.PubMedCrossRef Beaudoin M, Potvin S, Machalani A, Dellazizzo L, Bourguignon L, Phraxayavong K, et al. The therapeutic processes of avatar therapy: a content analysis of the dialogue between treatment-resistant patients with schizophrenia and their avatar. Clin Psychol Psychother. 2021;28(3):500–18.PubMedCrossRef
30.
go back to reference Hudon A, Beaudoin M, Phraxayavong K, Dellazizzo L, Potvin S, Dumais A. Implementation of a machine learning algorithm for automated thematic annotations in avatar: a linear support vector classifier approach. Health Inf J. 2022;28(4):14604582221142442. Hudon A, Beaudoin M, Phraxayavong K, Dellazizzo L, Potvin S, Dumais A. Implementation of a machine learning algorithm for automated thematic annotations in avatar: a linear support vector classifier approach. Health Inf J. 2022;28(4):14604582221142442.
31.
go back to reference Abargil M, Tishby O. How therapists’ emotion recognition relates to therapy process and outcome. Clin Psychol Psychother. 2022;29(3):1001–19.PubMedCrossRef Abargil M, Tishby O. How therapists’ emotion recognition relates to therapy process and outcome. Clin Psychol Psychother. 2022;29(3):1001–19.PubMedCrossRef
32.
go back to reference Kleinstauber M, Allwang C, Bailer J, Berking M, Brunahl C, Erkic M, et al. Cognitive Behaviour Therapy complemented with emotion regulation training for patients with persistent physical symptoms: a Randomised Clinical Trial. Psychother Psychosom. 2019;88(5):287–99.PubMedCrossRef Kleinstauber M, Allwang C, Bailer J, Berking M, Brunahl C, Erkic M, et al. Cognitive Behaviour Therapy complemented with emotion regulation training for patients with persistent physical symptoms: a Randomised Clinical Trial. Psychother Psychosom. 2019;88(5):287–99.PubMedCrossRef
33.
go back to reference Butler RM, Boden MT, Olino TM, Morrison AS, Goldin PR, Gross JJ, et al. Emotional clarity and attention to emotions in cognitive behavioral group therapy and mindfulness-based stress reduction for social anxiety disorder. J Anxiety Disord. 2018;55:31–8.PubMedPubMedCentralCrossRef Butler RM, Boden MT, Olino TM, Morrison AS, Goldin PR, Gross JJ, et al. Emotional clarity and attention to emotions in cognitive behavioral group therapy and mindfulness-based stress reduction for social anxiety disorder. J Anxiety Disord. 2018;55:31–8.PubMedPubMedCentralCrossRef
35.
go back to reference Kikutani M, Ikemoto M. Detecting emotion in speech expressing incongruent emotional cues through voice and content: investigation on dominant modality and language. Cogn Emot. 2022;36(3):492–511.PubMedCrossRef Kikutani M, Ikemoto M. Detecting emotion in speech expressing incongruent emotional cues through voice and content: investigation on dominant modality and language. Cogn Emot. 2022;36(3):492–511.PubMedCrossRef
36.
go back to reference Dellazizzo L, Potvin S, Phraxayavong K, Dumais A. One-year randomized trial comparing virtual reality-assisted therapy to cognitive-behavioral therapy for patients with treatment-resistant schizophrenia. NPJ Schizophr. 2021;7(1):9.PubMedPubMedCentralCrossRef Dellazizzo L, Potvin S, Phraxayavong K, Dumais A. One-year randomized trial comparing virtual reality-assisted therapy to cognitive-behavioral therapy for patients with treatment-resistant schizophrenia. NPJ Schizophr. 2021;7(1):9.PubMedPubMedCentralCrossRef
37.
go back to reference Mergenthaler E, Stinson C. Psychotherapy transcription Standards. Psychother Res. 2010;2(2):125–42.CrossRef Mergenthaler E, Stinson C. Psychotherapy transcription Standards. Psychother Res. 2010;2(2):125–42.CrossRef
41.
go back to reference Coan JA, Gottman JM. The specific Affect Coding System (SPAFF). Handbook of emotion elicitation and assessment. Series in affective science. New York, NY, US: Oxford University Press; 2007. pp. 267–85. Coan JA, Gottman JM. The specific Affect Coding System (SPAFF). Handbook of emotion elicitation and assessment. Series in affective science. New York, NY, US: Oxford University Press; 2007. pp. 267–85.
42.
go back to reference Sbattella L, Colombo L, Rinaldi C, Tedesco R, Matteucci M, Trivilini A, editors. Extracting Emotions and Communication Styles from vocal signals. PhyCS; 2014. Sbattella L, Colombo L, Rinaldi C, Tedesco R, Matteucci M, Trivilini A, editors. Extracting Emotions and Communication Styles from vocal signals. PhyCS; 2014.
43.
go back to reference Rochman D, Amir O. Examining in-session expressions of emotions with speech/vocal acoustic measures: an introductory guide. Psychother Res. 2013;23(4):381–93.PubMedCrossRef Rochman D, Amir O. Examining in-session expressions of emotions with speech/vocal acoustic measures: an introductory guide. Psychother Res. 2013;23(4):381–93.PubMedCrossRef
44.
go back to reference Lyons M, Aksayli ND, Brewer G. Mental distress and language use: linguistic analysis of discussion forum posts. Comput Hum Behav. 2018;87:207–11.CrossRef Lyons M, Aksayli ND, Brewer G. Mental distress and language use: linguistic analysis of discussion forum posts. Comput Hum Behav. 2018;87:207–11.CrossRef
45.
go back to reference Chomczynski P. QDA MINER – the mixed method solution for qualitative analysis by Provalis Research. Qualitative Sociol Rev. 2008;4(2):126–9.CrossRef Chomczynski P. QDA MINER – the mixed method solution for qualitative analysis by Provalis Research. Qualitative Sociol Rev. 2008;4(2):126–9.CrossRef
46.
go back to reference Given LM. The sage encyclopedia of qualitative research methods. Sage publications; 2008. Given LM. The sage encyclopedia of qualitative research methods. Sage publications; 2008.
47.
go back to reference Rus-Calafell M, Ehrbar N, Ward T, Edwards C, Huckvale M, Walke J, et al. Participants’ experiences of AVATAR therapy for distressing voices: a thematic qualitative evaluation. BMC Psychiatry. 2022;22(1):356.PubMedPubMedCentralCrossRef Rus-Calafell M, Ehrbar N, Ward T, Edwards C, Huckvale M, Walke J, et al. Participants’ experiences of AVATAR therapy for distressing voices: a thematic qualitative evaluation. BMC Psychiatry. 2022;22(1):356.PubMedPubMedCentralCrossRef
48.
go back to reference Susindar S, Sadeghi M, Huntington L, Singer A, Ferris TK. The Feeling is Real: Emotion Elicitation in Virtual Reality. Proceedings of the Human Factors and Ergonomics Society Annual Meeting. 2019;63(1):252-6. Susindar S, Sadeghi M, Huntington L, Singer A, Ferris TK. The Feeling is Real: Emotion Elicitation in Virtual Reality. Proceedings of the Human Factors and Ergonomics Society Annual Meeting. 2019;63(1):252-6.
49.
go back to reference Felnhofer A, Kothgassner OD, Schmidt M, Heinzle A-K, Beutl L, Hlavacs H, et al. Is virtual reality emotionally arousing? Investigating five emotion inducing virtual park scenarios. Int J Hum Comput Stud. 2015;82:48–56.CrossRef Felnhofer A, Kothgassner OD, Schmidt M, Heinzle A-K, Beutl L, Hlavacs H, et al. Is virtual reality emotionally arousing? Investigating five emotion inducing virtual park scenarios. Int J Hum Comput Stud. 2015;82:48–56.CrossRef
50.
go back to reference Potvin S, Tikasz A, Lungu O, Dumais A, Stip E, Mendrek A. Emotion processing in treatment-resistant schizophrenia patients treated with clozapine: an fMRI study. Schizophr Res. 2015;168(1–2):377–80.PubMedCrossRef Potvin S, Tikasz A, Lungu O, Dumais A, Stip E, Mendrek A. Emotion processing in treatment-resistant schizophrenia patients treated with clozapine: an fMRI study. Schizophr Res. 2015;168(1–2):377–80.PubMedCrossRef
51.
go back to reference Mothersill O, Knee-Zaska C, Donohoe G. Emotion and theory of mind in Schizophrenia-Investigating the role of the Cerebellum. Cerebellum. 2016;15(3):357–68.PubMedCrossRef Mothersill O, Knee-Zaska C, Donohoe G. Emotion and theory of mind in Schizophrenia-Investigating the role of the Cerebellum. Cerebellum. 2016;15(3):357–68.PubMedCrossRef
52.
go back to reference Gica S, Poyraz BC, Gulec H. Are emotion recognition deficits in patients with schizophrenia states or traits? A 6-month follow-up study. Indian J Psychiatry. 2019;61(1):45–52.PubMedPubMedCentral Gica S, Poyraz BC, Gulec H. Are emotion recognition deficits in patients with schizophrenia states or traits? A 6-month follow-up study. Indian J Psychiatry. 2019;61(1):45–52.PubMedPubMedCentral
53.
go back to reference Kegel LC, Brugger P, Fruhholz S, Grunwald T, Hilfiker P, Kohnen O, et al. Dynamic human and avatar facial expressions elicit differential brain responses. Soc Cogn Affect Neurosci. 2020;15(3):303–17.PubMedPubMedCentralCrossRef Kegel LC, Brugger P, Fruhholz S, Grunwald T, Hilfiker P, Kohnen O, et al. Dynamic human and avatar facial expressions elicit differential brain responses. Soc Cogn Affect Neurosci. 2020;15(3):303–17.PubMedPubMedCentralCrossRef
54.
go back to reference Prusinski T. The strength of Alliance in Individual Psychotherapy and Patient’s Wellbeing: the Relationships of the Therapeutic Alliance to psychological wellbeing, satisfaction with life, and flourishing in adult patients attending individual psychotherapy. Front Psychiatry. 2022;13:827321.PubMedPubMedCentralCrossRef Prusinski T. The strength of Alliance in Individual Psychotherapy and Patient’s Wellbeing: the Relationships of the Therapeutic Alliance to psychological wellbeing, satisfaction with life, and flourishing in adult patients attending individual psychotherapy. Front Psychiatry. 2022;13:827321.PubMedPubMedCentralCrossRef
55.
go back to reference Ardito RB, Rabellino D. Therapeutic alliance and outcome of psychotherapy: historical excursus, measurements, and prospects for research. Front Psychol. 2011;2:270.PubMedPubMedCentralCrossRef Ardito RB, Rabellino D. Therapeutic alliance and outcome of psychotherapy: historical excursus, measurements, and prospects for research. Front Psychol. 2011;2:270.PubMedPubMedCentralCrossRef
56.
go back to reference Souto T, Silva H, Leite A, Baptista A, Queirós C, Marques A. Facial emotion recognition: virtual reality program for facial emotion Recognition—A Trial Program targeted at individuals with Schizophrenia. Rehabilitation Couns Bull. 2019;63(2):79–90.CrossRef Souto T, Silva H, Leite A, Baptista A, Queirós C, Marques A. Facial emotion recognition: virtual reality program for facial emotion Recognition—A Trial Program targeted at individuals with Schizophrenia. Rehabilitation Couns Bull. 2019;63(2):79–90.CrossRef
57.
go back to reference Kraemer S, Lihl M, Mergenthaler E. Schlüsselstunden im Verlauf kognitiver Verhaltenstherapie von schizophrenen Patienten: Ein Beitrag zur Prozessforschung. Verhaltenstherapie. 2007;17(2):90–9.CrossRef Kraemer S, Lihl M, Mergenthaler E. Schlüsselstunden im Verlauf kognitiver Verhaltenstherapie von schizophrenen Patienten: Ein Beitrag zur Prozessforschung. Verhaltenstherapie. 2007;17(2):90–9.CrossRef
Metadata
Title
Exploration of the role of emotional expression of treatment-resistant schizophrenia patients having followed virtual reality therapy: a content analysis
Authors
Alexandre Hudon
Veronica Lammatteo
Sophie Rodrigues-Coutlée
Laura Dellazizzo
Sabrina Giguère
Kingsada Phraxayavong
Stéphane Potvin
Alexandre Dumais
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2023
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-023-04861-2

Other articles of this Issue 1/2023

BMC Psychiatry 1/2023 Go to the issue